Tysabri Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
Condition:   Multiple Sclerosis Intervention:   Drug: Cladribine Sponsors:   University of Texas Southwestern Medical Center;   EMD Serono Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 26, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri ®
Condition:   Relapsing-Remitting Multiple Sclerosis (RRMS) Intervention:   Biological: Intravenous (IV) infusions Sponsor:   Polpharma Biologics S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials